News

Filter

Current filters:

AllerganOphthalmics

Allergan’s Ozurdex approved for DME in Europe

Allergan’s Ozurdex approved for DME in Europe

02-09-2014

Allergan revealed today that the European Commission has extended the marketing authorization for Ozurdex…

AllerganEuropeOphthalmicsOzurdexPharmaceuticalRegulation

US FDA delays Allergan’s Semprana decision, approves Ozurdex

US FDA delays Allergan’s Semprana decision, approves Ozurdex

01-07-2014

US drugmaker Allergan, the subject of a hostile $53 billion takeover pursuit by Canada’s Valeant Pharmaceuticals…

AllerganBimatoprost Ophthalmic Solution 0.03% for GlaLevadexNeurologicalOphthalmicsOzurdexPharmaceuticalRegulationResearchSempranaUSA

Allergan faces law suit alleging payment of kickbacks to optometrists to prescribe Restasis

Allergan faces law suit alleging payment of kickbacks to optometrists to prescribe Restasis

14-02-2014

US drugmaker Allergan (NYSE: AGN) is the subject of legal action after allegations that it paid kickbacks…

AllerganLegalOphthalmicsPharmaceuticalRestasisUSA

Actavis confirms challenge to Allergan’s Restasis

22-01-2014

Generics drug major Actavis has confirmed that its Watson Laboratories unit has submitted an Abbreviated…

ActavisAllerganGenericsNorth AmericaOphthalmicsPatentsRegulationRestasisUSAWatson Pharmaceuticals

COMPANY SPOTLIGHT

Menarini

Back to top